Effects of evodiamine on ROS/TXNIP/NLRP3 pathway against gouty arthritis

Busso N, So A (2010) Gout. Mechanisms of inflammation in gout[J]. Arthritis Res Ther 12:206

Chen T, Xiong R, Liu W, Wang Z, Zhang X (2018) Application of Jiming San in the treatment of gout [J]. World’s latest medical information abstract. 18(98):245+247

Chu J, Thomas LM, Watkins SC et al (2009) Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. J Leukoc Biol 86(5):1227–1238

Article  PubMed  PubMed Central  CAS  Google Scholar 

Coderre TJ, Wall PD (1988) Ankle joint arthritis in rats provide a useful tool for the evaluation of analgesic and ant-arthritic agents[J]. Pharmacol Biochem Behav 29:261

Article  Google Scholar 

Engel B, Just J, Bleckwenn M, Weckbecker K (2017) Treatment options for gout. Deutsches Arzteblatt International 114(13):215–222

PubMed  PubMed Central  Google Scholar 

Fang Z, Tang Y, Ying J, Tang C, Wang Q (2020) Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa. Chin Med 15:82

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gavaraskar K, Dhulap S, Hirwani RR (2015) Therapeutic and cosmetic applications of Evodiamine and its derivatives--a patent review. Fitoterapia 106:22–35

Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662

Article  PubMed  Google Scholar 

Li M, Wang C (2020) Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: a review. J Ethnopharmacol 263:113231

Article  PubMed  CAS  Google Scholar 

Li X, Ge J, Zheng Q, Zhang J, Sun R, Liu R (2020) Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases. Phytomedicine 68:153180

Article  PubMed  CAS  Google Scholar 

Lv J, Lv F, Fang H, Wan S (2013) Study of acute gouty arthritis and hyperuricemia rat model (in Chinese) [J]. Chin J Mod Med 23(27):11–16

Munozplanillo R, Kuffa P, Martinezcolon G et al (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142–1153

Article  PubMed  CAS  Google Scholar 

Pillinger MH, Mandell BF (2020) Therapeutic approaches in the treatment of gout. Semin Arthritis Rheum 50(3S):S24–S30

Article  PubMed  CAS  Google Scholar 

Ragab G, Elshahaly M, Bardin T (2017) Gout: an old disease in new perspective - a review. J Adv Res 8(5):495–511

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rock KL, Kataoka H, Lai JJ (2013) Uric acid as a danger signal in gout and its comorbidities[J]. Nat Rev Rheumatol 9(1):13–23

Article  PubMed  CAS  Google Scholar 

Schumacher HR Jr, Becker MA, Wortmann RL et al (2008) Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 59(11):1540–1548

Article  PubMed  CAS  Google Scholar 

Song Y, Li J, Cheng Y, Lin Z, He B, Wang C (2015) Lowering effect of evodiamine dispersible tablets on uric acid in chickens (in Chinese) [J]. Chin J New Drugs 24(09):1057–1060+1064

Tao Z, Li J, Sheng R, Cheng Y, Tang Yi, Tan Y (2013) Experimental study on the effect of evodiamine dispersible tablets on decreasing serum uric acid, anti inflammation and analgesia (in Chinese)[J]. LiShiZhen Med Mater Med Res 24(05):1147–1148

CAS  Google Scholar 

Tian KM, Li JJ, Xu SW (2019) Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). Pharmacol Res 141:541–550

Article  PubMed  CAS  Google Scholar 

Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10(3):210–215

Article  PubMed  CAS  Google Scholar 

Wang B (2001) Clinical observation on the treatment of 36 cases of gouty arthritis with modified Jiming San [J]. Hunan Guiding J Tradit Chin Med Pharmacol (12):593–594

Weaver JS, Vina ER, Munk PL, Klauser AS, Elifritz JM, Taljanovic MS (2021) Gouty arthropathy: review of clinical manifestations and treatment, with emphasis on imaging. J Clin Med 11(1):166

Article  PubMed  PubMed Central  Google Scholar 

Wen H, Ting PY, O’Neill L (2012) A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation?[J]. Nat Immunol 13(4):352

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wen X, Yu E, Xu J, Zhang Y (2021) Clinical observation of acupoint application with Fructus Evodiae combined with celecoxib capsules in treating acute gouty arthritis with wind-cold-damp blockage syndrome[J]. J Guangzhou Univ Tradit Chin Med 38(02):330–335

Wortmann RL, Macdonald PA, Hunt B, Jackson RL (2010) Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clin Ther 32(14):2386–2397

Article  PubMed  CAS  Google Scholar 

Yao R, Geng Z, Mao X, Bao Y, Guo S, Bao L, Sun J, Gao Y, Xu Y, Guo B, Meng F, Cui X (2020) Tu-Teng-Cao extract alleviates monosodium urate-induced acute gouty arthritis in rats by inhibiting uric acid and inflammation. Evid Based Complement Alternat Med 2020:3095624

Article  PubMed  PubMed Central  Google Scholar 

Yu KH, Chen DY, Chen JH et al (2018) Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis 21(4):772–787

Article  PubMed  CAS  Google Scholar 

Zhao M, Chen T, Huang Z, Zhong Q (2021) Disease burden of gout in China, 1990–2019[J]. Modern Prev Med 48(21):3974–3978

Google Scholar 

Zhen-hua F, Waizy H (2013) Current concepts in the treatment of gouty arthritis. Orthop Surg 5(1):6–12

Article  Google Scholar 

留言 (0)

沒有登入
gif